Overall prescribing rates (GLP-1 RA prescriptions per total prescriptions) have remained stable in the last 3 months
At the same time, many peptides promoted for anti-aging, performance, bodybuilding, injury recovery and wellness are being sold far ahead of the human evidence, often through channels that raise serious quality concerns
The first is the most abundant showing MW of about 23.8 kDa, a pI of 9.5 and a pH optimum around neutrality (33)
Products have not been evaluated by the Food and Drug Administration (FDA)
What are the main risks of combining these two drugs
For weight management, NICE has approved liraglutide 3 mg (Saxenda) and semaglutide 2.4 mg (Wegovy) under specific criteria, including BMI thresholds and provision through specialist weight management services